BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38507053)

  • 1. Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models.
    Marvaso G; Isaksson LJ; Zaffaroni M; Vincini MG; Summers PE; Pepa M; Corrao G; Mazzola GC; Rotondi M; Mastroleo F; Raimondi S; Alessi S; Pricolo P; Luzzago S; Mistretta FA; Ferro M; Cattani F; Ceci F; Musi G; De Cobelli O; Cremonesi M; Gandini S; La Torre D; Orecchia R; Petralia G; Jereczek-Fossa BA
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38507053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
    Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
    Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of PSMA PET/MR radiomics for prostate cancer staging.
    Solari EL; Gafita A; Schachoff S; Bogdanović B; Villagrán Asiares A; Amiel T; Hui W; Rauscher I; Visvikis D; Maurer T; Schwamborn K; Mustafa M; Weber W; Navab N; Eiber M; Hatt M; Nekolla SG
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):527-538. PubMed ID: 34255130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of [
    Basso Dias A; Mirshahvalad SA; Ortega C; Perlis N; Berlin A; van der Kwast T; Ghai S; Jhaveri K; Metser U; Haider M; Avery L; Veit-Haibach P
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2167-2176. PubMed ID: 36809425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI-based radiomics combined with pathomics features for prediction of the efficacy of neoadjuvant chemotherapy in breast cancer.
    Xu N; Guo X; Ouyang Z; Ran F; Li Q; Duan X; Zhu Y; Niu X; Liao C; Yang J
    Heliyon; 2024 Jan; 10(2):e24371. PubMed ID: 38298695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of [
    Ghezzo S; Mapelli P; Bezzi C; Samanes Gajate AM; Brembilla G; Gotuzzo I; Russo T; Preza E; Cucchiara V; Ahmed N; Neri I; Mongardi S; Freschi M; Briganti A; De Cobelli F; Gianolli L; Scifo P; Picchio M
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2548-2560. PubMed ID: 36933074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification.
    Shu X; Liu Y; Qiao X; Ai G; Liu L; Liao J; Deng Z; He X
    Br J Radiol; 2023 Mar; 96(1143):20220238. PubMed ID: 36475858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature.
    Zhang L; Zhe X; Tang M; Zhang J; Ren J; Zhang X; Li L
    Contrast Media Mol Imaging; 2021; 2021():7830909. PubMed ID: 35024015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
    Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
    Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
    Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
    J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL.
    Lu Y; Li B; Huang H; Leng Q; Wang Q; Zhong R; Huang Y; Li C; Yuan R; Zhang Y
    Front Oncol; 2022; 12():1020317. PubMed ID: 36582803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer.
    Zheng H; Miao Q; Liu Y; Mirak SA; Hosseiny M; Scalzo F; Raman SS; Sung K
    Eur Radiol; 2022 Aug; 32(8):5688-5699. PubMed ID: 35238971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
    Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
    J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
    Hu C; Qiao X; Hu C; Cao C; Wang X; Bao J
    Cancer Imaging; 2024 Feb; 24(1):23. PubMed ID: 38326860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
    Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-based analysis of [
    Cysouw MCF; Jansen BHE; van de Brug T; Oprea-Lager DE; Pfaehler E; de Vries BM; van Moorselaar RJA; Hoekstra OS; Vis AN; Boellaard R
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):340-349. PubMed ID: 32737518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative image signature and machine learning-based prediction of outcomes in cerebral cavernous malformations.
    Jabal MS; Mohammed MA; Kobeissi H; Lanzino G; Brinjikji W; Flemming KD
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107462. PubMed ID: 37931483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study.
    Zhuang J; Kan Y; Wang Y; Marquis A; Qiu X; Oderda M; Huang H; Gatti M; Zhang F; Gontero P; Xu L; Calleris G; Fu Y; Zhang B; Marra G; Guo H
    Front Oncol; 2022; 12():785684. PubMed ID: 35463339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.